Sirios Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$80.2M |
| 2 |
JPMorgan Chase
JPM
|
+$80M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$53.5M |
| 4 |
Union Pacific
UNP
|
+$49.5M |
| 5 |
Becton Dickinson
BDX
|
+$40.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$126M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$42.3M |
| 3 |
HCA Healthcare
HCA
|
+$33.7M |
| 4 |
Acadia Healthcare
ACHC
|
+$26.9M |
| 5 |
Bank OZK
OZK
|
+$26.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.59% |
| 2 | Technology | 23.23% |
| 3 | Communication Services | 11.82% |
| 4 | Consumer Discretionary | 8.71% |
| 5 | Materials | 8.65% |
Similar funds
Sirios Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Sirios Capital Management held 49 positions worth $2.04B, up 14% from $1.79B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Sirios Capital Management deployed $125M of net new capital in Q4 2016, opening 10 new positions and adding to 11 existing holdings. Its largest new stake was JPMorgan Chase: 1,048,803 shares worth $90.5M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 18% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Bank OZK, an estimated $26.1M trimmed.
- Sirios Capital Management's largest Q4 2016 buy was JPMorgan Chase: 1,048,803 shares worth $90.5M.
- Sirios Capital Management added most to Sherwin-Williams in Q4 2016, an estimated $80.2M increase.
- Sirios Capital Management's biggest Q4 2016 reduction was Bank OZK, cutting an estimated $26.1M.
- Sirios Capital Management fully exited Allergan plc in Q4 2016, selling an estimated $126M.
- Sirios Capital Management's ten largest holdings make up 55% of its $2.04B portfolio in Q4 2016.
- Sirios Capital Management opened 10 new positions and closed 13 in Q4 2016.
- Sirios Capital Management's portfolio value rose 14% quarter-over-quarter to $2.04B.
Based on Sirios Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.